Investigation on Industry Prospects of Inhalation-type Drug Delivery Devices
Release time:
2022-08-10 13:23

Inhalation-type drug delivery devices are mainly used to treat and alleviate respiratory diseases including chronic obstructive pulmonary disease and asthma. This article summarizes the epidemiological data, market size forecasts, and public data on patent application trends for inhaled drug delivery devices to observe the development prospects of inhaled drug delivery devices from three perspectives..
In terms of epidemiological data, according to the World Health Organization, chronic obstructive pulmonary disease is the third leading cause of death worldwide,2019Year caused323Thousands died, and nearly90%of70Deaths from chronic obstructive pulmonary disease occur in low-and middle-income countries. In the asthma section,2019Annual2.62Billions of people have asthma problems and cause46.1Thousands died. From the epidemiological data, it is expected that inhaled drug delivery devices should have market potential due to the large number of patients with respiratory diseases.
In terms of market size forecasts, according to market research firmsAcumen「2019-2016 Global Inhaled Drug Market Forecast report,2026The global market for inhaled drugs is expected to reach415The size of the billion US dollars; according to the market research companyGII"Pulmonary Transport System Market:2021Year ~2026Forecast "report, market size of pulmonary drug delivery systems,2026Year is expected to reach569Billions of dollars. From the market size forecast data, market research companies are optimistic about the market development of inhaled drugs, and the market size of inhaled drug delivery devices can be expected to grow accordingly.
In terms of patent application trends, according to our research, throughIPCInternational Patent Classification InquiryA61M11/00(Nebulizer or nebulizer specially designed for therapeutic purposes),A61M15/00(inhaler)andA61M16/00(Apparatus for affecting the respiratory system of a patient by gas treatment, such as mouth-to-mouth breathing; tracheal intubation)The number of patent applications in the field of technology, such as the number of patent applications in the six patent office databases.(United States, Europe, China, Japan, South Korea and Taiwan)The patent application situation[1], found2015To2020The number of patent applications in the year showed a clear upward trend, with the number growing by about245%. From the patent application trend data, it can be seen that more and more patent applicants are actively involved in the patent layout of inhalation drug delivery devices.
In summary, due to the large number of patients with respiratory diseases, driving a huge demand for medication, it is reasonable to expect that the market size of inhaled drug delivery devices will continue to grow. In addition, from the observation of the number of patent applications, an obvious upward trend is also found. Therefore, we believe that the inhaled drug delivery device industry will show a positive development trend in the future.
Inhaled, inhaled, study, 00, company, chronic, death, global, obstructive